Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine Cervix

Double-Blinded Multicenter Clinical Study Assessing the Equivalence of the InPath Cervical Cell Collector to the Standard Endocervical Brush and Spatula in Patients Seeking Primary Pap Screening or Follow-up Screening

NCT00266084•University Hospitals Cleveland Medical Center

View on ClinicalTrials.gov

Summary

This study tested the safety and performance of a new cell collector device and compared the results to those obtained with the current existing device that are being used routinely

Detailed Description

This study tested the feasibility, safety and efficacy of the new e2TM Collector, and compared its performance with the standard method for obtaining cervical cells for Pap test of endocervical cytobrush and Ayer's Spatula

Eligibility

Age

14 - No limit years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Women ages \>14 being followed for a previous abnormal Pap All patients will have signed an Informed Consent form prior to being enrolled in this study

Exclusion Criteria

•Patients who have had a hysterectomy

Key Dates

Start Date

August 1, 1999

Completion Date

November 1, 2001

Last Updated

May 11, 2016

Enrollment

Estimated participants

Conditions

Uterine Cervical DysplasiaUterine Cervical Intraepithelial NeoplasiaUterine Cervical NeoplasiaUterine Cervical Cancer

Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples

NCT06598176

Uterine Cervical NeoplasmUterine Cervical Dysplasia+2 more

View study

RECRUITING

Conservative Management of HSIL in Patients With Future Pregnancy Aspiration

NCT04783805

Cervical Intraepithelial NeoplasiaSquamous Intraepithelial Lesions of the Cervix+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 11, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine Cervix

Inclusion Criteria

Exclusion Criteria

Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples

Conservative Management of HSIL in Patients With Future Pregnancy Aspiration

Lugol's Solution in Addition to Acetic Acid During Colposcopy

HIV Indicator Diseases in Hospital and Primary Care

Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix

Hemostatic Procedure After Biopsy of the Cervix